Reuters (3/17, Hirschler) reported on a venture capital fund, the Global Dementia Discovery Fund, established to research novel ways to prevent and treat dementia. The fund, which has the backing of the UK government and some of the world’s largest pharmaceutical companies, including GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer and Biogen Idec, has so far raised $100 million. The fund is the first of its kind to support dementia research. The AP (3/18, Johnson) and the Telegraph (UK) (3/18, Roland) also report on the story.
— “Dementia drug research aided by $100 million venture capital fund,”Ben Hirschler, Reuters, March 17, 2015.